Diagnosis of Scott syndrome in patient with bleeding disorder of unknown cause.

Scott syndrome is a rare bleeding disorder due to an impaired exposure of phosphatidilserine on the platelet membrane, compromising the platelet procoagulant activity, thrombin generation and, thus, the clot formation. We report a case of a 17-year-old female adolescent with bleeding episodes of unknown cause. She had normal coagulation, but altered platelet aggregation under arteriolar flow, indicating platelet dysfunction. Furthermore, the expression of Annexin V was markedly reduced and the diagnosis of Scott syndrome was established. She was treated with platelet transfusions and demonstrated a clinical improvement. Scott syndrome may be investigated in cases with bleeding history and normal coagulation tests.

[1]  J. Broers,et al.  Absence of platelet-dependent fibrin formation in a patient with Scott syndrome , 2009, Thrombosis and Haemostasis.

[2]  C. Male,et al.  Monitoring survival and function of transfused platelets in Bernard‐Soulier syndrome by flow cytometry and a cone and plate(let) analyzer (Impact‐R) , 2007, Transfusion.

[3]  A. Brill,et al.  Using Cone and Plate(let) Analyzer to Predict Bleeding in Cardiac Surgery , 2006, Asian cardiovascular & thoracic annals.

[4]  N. Savion,et al.  ADAMTS-13 regulates platelet adhesion under flow , 2006, Thrombosis and Haemostasis.

[5]  S. Béguin,et al.  New approaches for measuring coagulation , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  P. Comfurius,et al.  Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. , 2004, Biochimica et biophysica acta.

[7]  J. Heemskerk,et al.  Store-mediated calcium entry in the regulation of phosphatidylserine exposure in blood cells from Scott patients , 2003, Thrombosis and Haemostasis.

[8]  P. Comfurius,et al.  Mechanism and function of changes in membrane-phospholipid asymmetry in platelets and erythrocytes. , 1993, Biochemical Society transactions.

[9]  H. Hemker,et al.  Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. , 1985, Blood.

[10]  N. Savion,et al.  CHAPTER 29 – Impact Cone and Plate(let) Analyzer , 2007 .